Molnupiravir, also known by its brand name Lagevrio, represents a important advancement in the battle against COVID-19. This taken by mouth antiviral medicine works by introducing errors into the virus's genetic code, effectively halting its copying and spread within the body. While first data suggested a considerable reduction in admission to hosp